Kymera Therapeutics (KYMR)
(Delayed Data from NSDQ)
$42.30 USD
+3.30 (8.46%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $42.29 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.69 | -12.50% |
Earnings Summary
For their last quarter, Kymera Therapeutics (KYMR) reported earnings of -$0.69 per share, beating the Zacks Consensus Estimate of $-0.73 per share. This reflects a positive earnings surprise of 5.48%. Look out for KYMR's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.69 per share, reflecting a year-over-year decrease of 2.99%.
Earnings History
Price & Consensus
Zacks News for KYMR
Kymera Therapeutics (KYMR) Surges 23.4%: Is This an Indication of Further Gains?
KYMR: What are Zacks experts saying now?
Zacks Private Portfolio Services